Welcome to the home page of Børre Fevang's research group

Immunopathogenic mechanisms in immunodeficiency and infectious disorders

Børre Fevang

Group leader Børre Fevang, MD, PhD
PhD Student Linn Landrø, MD
PhD Student Elisabeth Strand, MD
PhD Student Kristian Rødland, MD
Associated Researcher Torgun Wæhre MD, PhD
Professor Stig S. Frøland, MD, PhD

Print this page [234 visits]

News & events

Presentation of prestigious research project
Actionable Targets in Cancer Metastasis (MetAction) – from Bed to Bench to Byte to Bedside
May 16, 2012

GAP cancer conference in Oslo May 14-16
Global Academic Programs 2012
May 11, 2012

Trial lecture and disputation May 9th
Trevor Clancy
May 8, 2012

Study by Ane Hansen Kjenseth et al. featured on the cover of Journal of Biological Chemistry
May 7, 2012

Institute Seminar - Wednesday May 9th
Tor Erik Rusten
May 7, 2012

More news

Latest publications

Børge Fevang

Gregersen S, Aaløkken TM, Mynarek G, Fevang B, Holm AM, Ueland T, Aukrust P, Kongerud J, Johansen B, Frøland SS (2010)
Development of pulmonary abnormalities in patients with common variable immunodeficiency: associations with clinical and immunologic factors
Ann Allergy Asthma Immunol, 104 (6), 503-10
PubMed 20568383

Fevang B, Eugen-Olsen J, Yndestad A, Brosstad F, Beiske K, Aukrust P, Frøland SS (2009)
Enhanced levels of urokinase plasminogen activator and its soluble receptor in common variable immunodeficiency
Clin Immunol, 131 (3), 438-46
PubMed 19232508

Damås JK, Landrø L, Fevang B, Heggelund L, Frøland SS, Aukrust P (2009)
Enhanced levels of the CCR7 ligands CCL19 and CCL21 in HIV infection: correlation with viral load, disease progression and response to highly active antiretroviral therapy
AIDS, 23 (1), 135-8
PubMed 19050397

More publications